Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (10): 1090-1095.doi: 10.3969/j.issn.1000-6621.2019.10.005
• Original Articles • Previous Articles Next Articles
Wei HE,Qing CHEN,Tao HUANG,Xiao-qiu HUANG,Gui-hui WU()
Received:
2019-04-10
Online:
2019-10-10
Published:
2019-10-09
Contact:
Gui-hui WU
E-mail:wghwgh2584@sina.com
Wei HE,Qing CHEN,Tao HUANG,Xiao-qiu HUANG,Gui-hui WU. The changes in peripheral blood of T lymphocyte subsets in patients with pulmonary tuberculosis and extra-pulmonary tuberculosis and its clinical significance[J]. Chinese Journal of Antituberculosis, 2019, 41(10): 1090-1095. doi: 10.3969/j.issn.1000-6621.2019.10.005
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.10.005
组别 | 例数 | CD3+ [个/μl,M(Q1,Q3)] | CD4+ [个/μl,M(Q1,Q3)] | CD8+ [个/μl,M(Q1,Q3)] | CD4+/CD8+ [M(Q1,Q3)] |
---|---|---|---|---|---|
肺结核 | 63 | 698.000 (572.000,904.000) | 409.000 (311.000,545.000) | 244.000 (154.000,317.000) | 1.770 (1.290,2.350) |
肺结核并发肺外结核 | 60 | 596.000 (377.500,823.250) | 347.500 (214.000,479.250) | 195.500 (137.250,278.750) | 1.670 (1.258,2.273) |
肺外结核 | 24 | 551.500 (283.750,949.000) | 295.500 (134.250,461.750) | 185.000 (92.000,366.250) | 1.455 (1.018,2.128) |
H值 | 8.900 | 8.989 | 4.506 | 2.132 | |
P值 | 0.012 | 0.011 | 0.105 | 0.344 |
[1] | World Health Organization. Global tuberculosis report 2018. Geneva: World Health Organization, 2018. |
[2] | 中华人民共和国国家卫生和计划生育委员会. WS 196—2017 中华人民共和国卫生行业标准结核病分类.北京: 人民卫生出版社, 2017. |
[3] | Peto HM, Pratt RH, Harrington TA , et al. Epidemiology of extrapulmonary tuberculosis in the United States, 1993—2006. Clin Infect Dis, 2009,49(9):1350-1357. |
[4] | Sandgren A, Hollo V, van der Werf MJ . Extrapulmonary tuberculosis in the European Union and European Economic Area,2002 to 2011. Euro Surveill, 2013,18(12):pii: 20431. |
[5] | Pang Y, An J, Shu W , et al. Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008—2017. Emerg Infect Dis, 2019,25(3):457-464. |
[6] | Walzl G, McNerney R, du Plessis N , et al. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. Lancet Infect Dis, 2018,18(7):e199-e210. |
[7] | Zhao Y, Bu H, Hong K , et al. Genetic polymorphisms of CCL1 rs2072069 G/A and TLR2 rs3804099 T/C in pulmonary or meningeal tuberculosis patients. Int J Clin Exp Pathol, 2015,8(10):12608-12620. |
[8] | Leeds IL, Magee MJ, Kurbatova EV , et al. Site of extrapulmonary tuberculosis is associated with HIV infection. Clin Infect Dis, 2012,55(1):75-81. |
[9] | Naing C, Mak JW, Maung M , et al. Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung, 2013,191(1):27-34. |
[10] | Lewinsohn DA, Gennaro ML, Scholvinck L , et al. Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int J Tuberc Lung Dis, 2004,8(5):658-674. |
[11] | Xiao J, Sun L, Wu XR , et al. Association of immunophenotypic characterization of peripheral lymphocytes with different clinical phenotypes of tuberculosis in Chinese Han children. Chin Med J (Engl), 2012,125(2):275-280. |
[12] | Ramírez-Lapausa M, Menéndez-Saldaña A, Noguerado-Asensio A . Extrapulmonary tuberculosis an overview. Rev Esp Sanid Penit, 2015,17(1):3-11. |
[13] | Krishnan N, Robertson BD, Thwaites G . The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis. Tuberculosis (Edinb), 2010,90(6):361-366. |
[14] | Al-Attiyah R, El-Shazly A, Mustafa AS . Comparative analysis of spontaneous and mycobacterial antigen-induced secretion of Th1, Th2 and pro-inflammatory cytokines by peripheral blood mononuclear cells of tuberculosis patients. Scand J Immunol, 2012,75(6):623-632. |
[15] | Darrah PA, Patel DT, De Luca PM , et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med, 2007,13(7):843-850. |
[16] | Wu J, Ma H, Qu Q , et al. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice. Vaccine, 2011,29(44):7624-7630. |
[17] | Silva BDS, Trentini MM, da Costa AC , et al. Different phenotypes of CD8 + T cells associated with bacterial load in active tuberculosis . Immunol Lett, 2014,160(1):23-32. |
[18] | Kumar NP, Sridhar R, Nair D , et al. Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis. Immunology, 2015,144(4):677-686. |
[19] | Antas PR, Ding L, Hackman J , et al. Decreased CD4 + lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis . J Allergy Clin Immunol, 2006,117(4):916-923. |
[20] | Sharma RK, Gupta A, Kamal S , et al. Role of Regulatory T Cells in Tubercular Uveitis. Ocul Immunol Inflamm, 2018,26(1):27-36. |
[21] | Koziol-Montewka M, Kolodziejek A, Oles J , et al. Proinflammatory cytokine profile in active kidney tuberculosis patients. Immunol Invest, 2004,33(3):277-285. |
[22] |
张少俊, 肖和平 . 复治肺结核与初治结核病患者外周血T细胞亚群等的变化及其意义. 中华结核和呼吸杂志, 2011,34(12):884-887.
doi: 10.3760/cma.j.issn.1001-0939.2011.12.002 |
[23] | 杜光明 . 肺结核和肺外结核患者外周血淋巴细胞亚群的检测意义探讨. 临床肺科杂志, 2014,19(4):693-695. |
[24] | 孔祥瑞, 肖漓, 石炳毅 , 等. 肺结核和肺外结核患者外周血淋巴细胞亚群的表达及临床意义. 临床误诊误治, 2013,26(1):79-81. |
[25] | Yao S, Huang D, Chen CY , et al. CD4 + T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8 + T and CD3- lymphocytes: mechanisms of CD4 + T cell immunity . J Immunol, 2014,192(5):2120-2132. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||